Executive leadership

Ken Knight , , , President and Chief Executive Officer

Ken leads the Invitae team on its mission to bring genetic information into mainstream medicine to help improve healthcare for billions of people. Before becoming the company's President and CEOKen served as Invitae's chief operating officer from June 2020 to July 2022. Ken is also a member of the board at Invitae. Prior to joining Invitae, he most recently served as vice president of transportation services at Amazon.com, Inc. from December 2019 to June 2020, and as vice president of Amazon's global delivery services and worldwide fulfillment human resources from April 2016 to December 2019. From 2012 to 2016, he served as general manager of the material handling and underground division, a global business with $6 billion in annual revenue, at Caterpillar Inc. In his earlier career, Ken served in various capacities at General Motors Company for 27 years, including as executive director of global manufacturing engineering and as manufacturing general manager. Since June 2021, Ken has served as a director and a member of the audit and finance committee of Simpson Manufacturing Co. Inc. Ken holds a B.S. in Electrical Engineering from the Georgia Institute of Technology and an M.B.A from the Massachusetts Institute of Technology.

Robert Dickey , , , Interim Chief Financial Officer

Robert Dickey IV joined Invitae as interim chief financial officer in August 2023. He is a finance executive with over 25 years experience as a CFO as well as other C-level and board positions at both private and publicly traded life sciences and medical device companies. Robert is experienced in all stages of the corporate lifecycle, including start-up and fundraising, the IPO process, high growth and turnarounds as well as interactions with directors, shareholders and the investment community. Earlier in his career, he spent 18 years in investment banking, mostly at Lehman Brothers, with a background divided between M&A and capital markets transactions. As a part-time or interim CFO, Rob has consulted with more than 10 companies in the life sciences space. He currently serves as a member of the Board of Directors at AngioGenex, SFA Therapeutics and GSNO Therapeutics. Rob holds an MBA from The Wharton School, University of Pennsylvania, and an AB from Princeton University. Robert holds an MBA from The Wharton School, University of Pennsylvania, and an AB from Princeton University.

Tom Brida , , , General Counsel, Chief Compliance Officer and Secretary

Tom leads the legal and compliance team at Invitae. Tom has a broad-based legal background in the life science and diagnostic industries, having advised both public and private multinational companies on transactional and corporate matters. Prior to joining Invitae, Tom served as associate general counsel at Bio-Rad Laboratories and associate in Orrick's corporate and technology group. Tom holds a B.A. from Stanford University and a law degree from U.C. Berkeley School of Law.

Robert Guigley , , , Chief Commercial Officer

Robert Guigley joined Invitae as chief commercial officer in September 2023. In this role, Robert leads Invitae’s commercial strategy with a focus on driving profitable revenue growth, expanding the market, improving reimbursement levels and enhancing the service of clients and patients. 

Robert is an industry veteran with more than 20 years of commercial experience spanning biotechnology, pharmaceuticals, diagnostics and genetic testing. He has a deep understanding of the long-term prospects of genetic information, along with extensive experience working with payors.

Most recently, Robert served as the chief commercial officer at Ambry Genetics where he was responsible for executing their commercial strategy and overseeing commercial sales, business development, client services, managing genetic specialists and expanding market access. He began his career in pharmaceutical sales at AstraZeneca, giving him a strong foundation in selling to physicians. He then migrated into diagnostics, leading sales and market access at Quest Diagnostics and Counsyl. 

Robert earned his MBA at Boston University Questrom School of Business and his BS at the University of Pittsburgh, where he focused on economics, math and philosophy.

Desarie French , , , Chief Talent Officer

Desarie leads People & Culture at Invitae in sourcing, recruiting, developing, training and retaining the company’s most valuable asset: our team. Prior to joining Invitae, Desarie served in various human resources leadership roles at Thermo Fisher Scientific, serving multiple functions, businesses and regions with expertise in talent acquisition, M&A and regional leadership roles. Desarie holds a B.A. in Business from Cal Poly, SLO and an M.S. in Employee Relations from Penn State. Desarie has spent most of her career in the healthcare/biotech industry with a passion for building great teams in organizations committed to creating a healthier tomorrow.

Robert Nussbaum , , M.D. , , Chief Medical Officer

Dr. Nussbaum leads Invitae’s medical team, which is driving forward the science and practice of medical genetics and improving clinical understanding of how to use genetics to improve patient care. Prior to joining Invitae, he was chief of the Division of Genomic Medicine at UCSF Health where he also held leadership roles in the Cancer Genetics and Prevention Program, and the Program in Cardiovascular Genetics, as well as serving as a member of the UCSF Institute for Human Genetics. Earlier, Dr. Nussbaum was chief of the Genetic Disease Research Branch of the National Human Genome Research Institute, one of the National Institutes of Health. He is a member of the National Academy of Medicine and a fellow at the American Academy of Arts and Sciences. Dr. Nussbaum is a board-certified internist and medical geneticist who holds a B.S. in Applied Mathematics from Harvard College and an M.D. from Harvard Medical School in the Harvard-MIT joint program in Health Sciences and Technology. He completed his residency in internal medicine at Barnes-Jewish Hospital and a fellowship in medical genetics at the Baylor College of Medicine.

Investor Toolkit

Feature Presentation

Email Alerts

Sign up to receive Invitae financial information by email.
Email Address: *

Enter the code shown above.

Investor Contact

1400 16th St.
San Francisco, CA, 94103
Email: ir@invitae.com